Drug profile · INN
panobinostat
FARYDAK
panobinostat (FARYDAK) is a histone deacetylase inhibitor.
EMA: approved Antineoplastic and immunomodulating agents (L01) L01XH03
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — panobinostat
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 7
- Data quality
- 0.83
Quick answer
panobinostat (FARYDAK) is a histone deacetylase inhibitor.
Key facts
INN panobinostat
Brand FARYDAK
Mechanism Histone deacetylase inhibitor
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XH03
Mechanism of action
Histone deacetylase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is panobinostat?
panobinostat (FARYDAK) is a histone deacetylase inhibitor.
What is the brand name for panobinostat?
FARYDAK is a marketed brand name for panobinostat. Check FDA Drugs@FDA for the current US label holder and prescribing information.